featured
Efficacy of Intramuscular AZD7442 (Tixagevimab–Cilgavimab) for the Prevention of COVID-19
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
The New England Journal of Medicine
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Intramuscular AZD7442 (Tixagevimab-Cilgavimab) for Prevention of Covid-19
N. Engl. J. Med 2022 Apr 20;[EPub Ahead of Print], MJ Levin, A Ustianowski, S De Wit, O Launay, M Avila, A Templeton, Y Yuan, S Seegobin, A Ellery, DJ Levinson, P Ambery, RH Arends, R Beavon, K Dey, P Garbes, EJ Kelly, GCKW Koh, KA Near, KW Padilla, K Psachoulia, A Sharbaugh, K Streicher, MN Pangalos, MT EsserFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.